These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 6432386)

  • 1. Differential precipitation of the Clq subcomponent of the first complement component (C1) by polyethylene glycol from normal human serum and sera of patients with collagen diseases.
    Van Dijk H; Van Voorst J; Jankowski IG; Imhof JW; Kerckhaert JA
    Clin Exp Immunol; 1984 Aug; 57(2):495-501. PubMed ID: 6432386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating immune complexes and rheumatoid arthritis.
    Faaber P; Rijke Schilder TP; Capel PJ; Koene RA
    J Rheumatol; 1985 Oct; 12(5):849-53. PubMed ID: 3878875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of complement components in polyethylene glycol precipitated immune complexes from patients with ovarian cancer and patients with rheumatoid arthritis.
    Mooney NA; Hay FC; Poulton TA
    Clin Exp Immunol; 1983 Jun; 52(3):561-8. PubMed ID: 6603297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of immune complexes detectable by two independent assays in gynaecological malignancies.
    Poulton TA; Mooney NA; Nineham LJ; Hay FC
    Clin Exp Immunol; 1983 Sep; 53(3):573-80. PubMed ID: 6604605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of immune complexes by a new assay, the polyethylene glycol precipitation-complement consumption test (PEG-CC).
    Harkiss GD; Brown DL
    Clin Exp Immunol; 1979 Apr; 36(1):117-29. PubMed ID: 111880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-C1q column: ligand specific purification of immune complexes from human serum or plasma. Analysis of the interaction between C1q and immune complexes.
    Kilgallon W; Amlot PL; Williams BD
    Clin Exp Immunol; 1982 Jun; 48(3):705-14. PubMed ID: 6811171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The detection of circulating immune complexes containing immunoglobulin G.
    Valentijn RM; van Es LA; Westedt ML; Daha MR
    J Clin Lab Immunol; 1984 Jun; 14(2):73-9. PubMed ID: 6748049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of immune complexes. The use of radioimmunoassays with Clq and monoclonal rheumatoid factor.
    Gabriel A; Agnello V
    J Clin Invest; 1977 May; 59(5):990-1001. PubMed ID: 323292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating immune complexes in patients with IgA glomerulonephritis.
    Nagy J; Füst G; Ambrus M; Trinn C; Paál M; Burger T
    Acta Med Acad Sci Hung; 1982; 39(3-4):211-8. PubMed ID: 6985242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interaction between fibronectin and aggregated IgG].
    Menzel EJ; Borth W; Kaik B
    Wien Klin Wochenschr; 1983 Dec; 95(24):880-4. PubMed ID: 6608184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of sera from ovarian cancer patients for immune complexes.
    Witkin SS; Bongiovanni AM; Armbruster T; Birnbaum S; Caputo T
    J Clin Lab Immunol; 1984 Jun; 14(2):65-8. PubMed ID: 6748047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statistical analysis of five immune complex screening assays: patterns of detection in patients with rheumatoid arthritis, systemic lupus erythematosus, infectious endocarditis, and diabetes mellitus.
    Kilpatrick JM; Virella G
    Diagn Immunol; 1983; 1(2):57-63. PubMed ID: 6388965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The detection of circulating immune complexes containing C1q and IgG using a new rapid serum ELISA test system.
    Reckel RP; Harris J; Botsko E; Wellerson R; Varga S
    Diagn Immunol; 1984; 2(4):228-37. PubMed ID: 6335421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating immune complexes and rheumatoid arthritis: the induction of immune complex formation between rheumatoid factor and IgG by polyethylene glycol.
    Faaber P; van den Bersselaar LA; van de Putte L; van den Berg WB
    J Rheumatol; 1989 Oct; 16(10):1304-9. PubMed ID: 2681758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunochemical analyses of components of immune complexes in the sera of patients with autoimmune diseases.
    Ferraccioli G; Karsh J; Osterland CK
    J Rheumatol; 1983 Dec; 10(6):881-8. PubMed ID: 6663592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and characterization of the 1q subcomponent of canine complement and its use in the 125I-C1q binding assay for detection of immune complexes.
    Wu CC; Bey RF; Loken KI
    Am J Vet Res; 1988 Jun; 49(6):865-9. PubMed ID: 3135770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitation and characterization of soluble immune complexes precipitated from sera by polyethylene glycol (PEG).
    Chia D; Barnett EV; Yamagata J; Knutson D; Restivo C; Furst D
    Clin Exp Immunol; 1979 Sep; 37(3):399-407. PubMed ID: 315842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of immune-complex size and antigen-antibody ratio on immune complex detection with monoclonal rheumatoid factor and C1q.
    Vanham G; Bloemmen FJ; Ceuppens JL; Stevens EA
    J Clin Lab Immunol; 1984 Oct; 15(2):63-8. PubMed ID: 6335179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C1q-latex assay for immune complexes. Complexes that react with both C1q and monoclonal rheumatoid factor in lupus erythematosus and lung cancer.
    Medof ME
    J Lab Clin Med; 1982 May; 99(5):678-92. PubMed ID: 6978370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgG subclasses of PEG precipitable IgG in systemic lupus erythematosus sera.
    Morland C; Michael J; Adu D
    Clin Nephrol; 1989 Apr; 31(4):204-9. PubMed ID: 2714025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.